News & Articles

Lightblades spectrophotometers line are designed for use with CRAIC microscope spectrophotometers

m2p-labs, BioLector family of products acquired by Beckman Coulter Life Sciences in 2020

Find out how a pioneering precision medicine company is using cell counting technology to improve patient outcomes

Both new antibody tests help healthcare teams differentiate the cause of antibodies against SARS-CoV-2

Explore topics from micro- and nanoscale LC-MS analysis to NGS sample quality control, EEM and A-TEEM spectroscopy, and oligonucleotide analysis

Innovation and growth remain a priority to support customers and COVID-19 initiatives

Highly complementary cell counting and analysis capabilities bolster preclinical portfolio and enhance QA/QC capabilities in cell and gene therapy and biologics manufacturing

The Simplexa™ SARS-CoV-2 Variants Direct assay aims to enable detection of four mutations associated with virus variants without requiring upfront RNA extraction

Integrated fluorescence light microscope combines light and electron microscopy into one system, removes complication of transferring samples between microscopes

Dr. Neha Mittal shares the secrets to successful wastewater viral testing at UNCC and discusses the part it could play in controlling future outbreaks

The availability of an International Standard (IS) for antibodies facilitates the standardization of SARS-CoV-2 serological methods

Ranya Badran, Corning, discusses the importance of sample preservation over time and reveals state-of-the-art cooling tools that protect precious samples

Dr. Sandra Leibel, USCD and Rady Children’s Hospital, discusses physiologically relevant lung organoids, the power of automated live-cell imaging and the search for new biotherapeutics

Simplified design reduces manufacturing time and offers improved functionality to help streamline antibody discovery, cell line development, cell therapy, and synthetic biology workflows

Platform poised to be first CLIA-waived CRISPR-based, point-of-care COVID-19 device with central-lab performance, developed in collaboration with Sherlock Biosciences

Explore topics from live-cell analysis, in situ hybridization, cancer therapeutics, cell imaging, and much more

Genome editing experts harness the power of CRISPR-Cas enzymes to power the next diagnostic revolution in COVID-19 detection and diagnosis

Explore topics from perfume profiling, salmonella spp. detection, regulatory biopharma compliance, and in situ hybridization